We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 1.12% | 452.50 | 445.00 | 460.00 | 452.50 | 447.50 | 447.50 | 18,692 | 14:20:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 48.09 | 214.49M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/7/2018 08:35 | Am a little disappointed that departing board members did not show more conviction and hold for FDA result next year. | zipstuck | |
16/7/2018 18:05 | "Satisfy market demand" phrase was used during a similar director placing in April last year. Price then was 175p. Hopefully these latest sales are not an omen of something sinister. Difficult to understand the orchestrated selling when US project has finally achieved a product approval milestone and potential comes closer... Perhaps Soler and Barnes need some money to pump into MobileODT. Only Swinney confirms in the later statement that he won't sell more shares "in the foreseeable future" | tmfmayn | |
16/7/2018 16:56 | My thoughts exactly | best1467 | |
16/7/2018 14:37 | Looks like we know the reason for last weeks weakness then - clearly some in the know. I wish they wouldn't use the phrase "to satisfy institutional demand" - just so condescending. Just say you want to offload some shares and we'd respect you a lot more rather than trying to dress it up. Might be an interesting open day tomorrow now | davr0s | |
15/7/2018 17:07 | 13 July, 2018 - 11:05 By Tony Quested Tristel goes for the burn in US after record performance nothing new except ... for the photo | piedro | |
14/7/2018 10:05 | Added a few k more at just over £2.90 | eentweedrie | |
14/7/2018 10:02 | H2 to H1 shows better sales growth momentum and is encouraging before the anticipated ramp up in sales in the US next year. | zipstuck | |
13/7/2018 12:01 | "Now, it is time for me to announce my retirement. I shall step down as Chair and director at our AGM in December. The Board has taken its first steps to initiate the search for a new Chairman and we intend to refresh the Board as we look to follow the guidelines of the Quoted Company Alliance Corporate Governance Code for Small and Mid-Size Quoted Companies. I remain a long-term supporter of Tristel." A very important announcement - Interim Chairman retiring and refreshing of the Board. This indicates that they consider that Tristel is ready to become an 'international company' and that requires a board of directors with a different perspective. AIMHO What the "Quoted Company Alliance Corporate Governance Code for Small and Mid-Size Quoted Companies" is I don't know but costs £55 to download a copy. | piedro | |
13/7/2018 10:52 | The value is in the next FDA approval | zipstuck | |
13/7/2018 09:45 | May be an opportunity to top up as this seems the usual market response to what is a fairly decent update. Sad to see the Chairman go but I'm sure they will find a capable replacement and further approvals stateside plus, crucially, actual sales in the US should push the price onwards to 350. | zimbtrader | |
13/7/2018 09:36 | I trade and screen out the story as its all noise/bias as far as I'm concerned. So to me we have sellers willing to sell price down and buyers not yet willing to bid it up. Suspect there were stops sitting sub 300 that got hit. I review EOD so will take stock then and see if 300 has held or not | davr0s | |
13/7/2018 09:33 | Not familiar with the story here, is it just in line numbers on a high rating or chairman leaving? | its the oxman | |
13/7/2018 09:01 | Yeah this is all really encouraging/fantasti | davr0s | |
13/7/2018 07:29 | excellent! | eentweedrie | |
13/7/2018 07:25 | Yet another encouraging trading update Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, provides a trading update for the year ended 30 June 2018 in advance of the Shareholder Open Day to be held at its headquarters in Snailwell, Cambridgeshire on Tuesday 17 July. For the year ended 30 June 2018 results will be in line with expectations, showing strong growth across the business. Tristel will report record turnover of £22.2m (2017: £20.3m) and pre-tax profit (before share-based payments) of at least £4.4m (2017: £4.1m). Revenue from overseas markets contributed 51.3% of the Group total - a record level (2017: 47%). Tristel has continued to generate significant levels of cash and at 30 June 2018 cash balances were £6.7m (30 June 2017: £5.1m). The Company has no debt. The Company will declare a final dividend for the year ended 30 June 2018 at the time of the preliminary results to be announced in October. for the complete RNS see - | metis20 | |
14/6/2018 12:18 | A couple of continuation type chart patterns confirmed over last day or two. Min tp's 372 and 292 Potential turn 21-22/6/2018 Bought a few. | bamboo2 | |
13/6/2018 15:59 | Looking pristine today! 350p within touching distance and as long as you wipe your hands afterwards that can't be a bad thing! Any news about being allowed to sell in one of the larger states should send this one buzzing! | mach100 | |
13/6/2018 14:22 | Can't make it again but will eagerly and gratefully await updates from those closer and able to fit it in. Gotta time my weeks off better in future! | zimbtrader | |
13/6/2018 08:32 | Reminder ... 08 June 2018 Tristel plc Shareholder Open Day /b> Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that it will hold an Open Day for Shareholders at the Company headquarters in Snailwell, Cambridgeshire from noon on Tuesday 17 July 2018. The day will provide an opportunity for shareholders to meet the Senior Management team, take a tour of the facility and familiarise themselves with the Company's products. Availability is limited so please contact Walbrook PR via tristel@walbrookpr.c | piedro | |
10/5/2018 09:08 | Amati AIM VCT significantly upped their position. | glaws2 | |
08/5/2018 23:15 | - member since 08 May 2018 - same on various sites > > > filtered | piedro | |
08/5/2018 22:16 | Automatically earn 10$ in your account when you register a free account in this investment platform, i have tried it and earn the 10$ give away bonus it true, you check it out and earn yours now https://jmktradings. | frankpondish | |
08/5/2018 11:41 | FWIW, TSTL Level II chart, - showing the bid and the offer spread | piedro | |
26/4/2018 09:02 | I think we are about to move out of our trading range to new highs. Lots of good US to come and all completed by year end and first revenues from there in this FY. I expect 350p in short order. | mach100 | |
23/4/2018 09:16 | Good jump today and looks like it wasn;t priced in as we head to record highs. This was 314p mid in August and we could surpass that unless Profit takers move in on the rise. The fact that the revenue will come in the current financial year helps as well as completion by year end. A significant risk has been removed and with some good news flow of states' approval tis could help teh share price to 400p. | mach100 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions